Alliance has an impressive and diverse deal history. Our acquisitions have been made from several of the world's top blue chip pharmaceutical companies, as well as various smaller ones.

We will assess divestments of individual brands, portfolios, subsidiaries and whole companies across any therapy area or geography.

We understand the brand attributes which have been developed over many years and will strive to maintain and improve any acquisitions completed.  We have a well practiced and professional team with an integrated approach across finance, manufacturing, regulatory and marketing. We aim to make the brand transfer as smooth as possible minimising the diversion of your resources.

As partners for divestment, Alliance uses the highest quality legal and financial advisors to structure a mutually beneficial business alliance.

If you are considering divesting a brand, please contact Alliance for an informal preliminary assessment.